Cargando…

Prevalence of the CYP2C19*2 (681 G>A), *3 (636 G>A) and *17 (−806 C>T) alleles among an Iranian population of different ethnicities

Polymorphisms in the cytochrome P (CYP) 450 family may cause adverse drug responses in individuals. Cytochrome P450 2C19 (CYP2C19) is a member of the CYP family, where the presence of the 681 G>A, 636 G>A and 806 C>T polymorphisms result in the CYP2C19*2, CYP2C19*3 and CYP2C19*17 alleles, r...

Descripción completa

Detalles Bibliográficos
Autores principales: Dehbozorgi, Mahshid, Kamalidehghan, Behnam, Hosseini, Iman, Dehghanfard, Zahra, Sangtarash, Mohammad Hossein, Firoozi, Maryam, Ahmadipour, Fatemeh, Meng, Goh Yong, Houshmand, Massoud
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5802190/
https://www.ncbi.nlm.nih.gov/pubmed/29328413
http://dx.doi.org/10.3892/mmr.2018.8377
_version_ 1783298496567181312
author Dehbozorgi, Mahshid
Kamalidehghan, Behnam
Hosseini, Iman
Dehghanfard, Zahra
Sangtarash, Mohammad Hossein
Firoozi, Maryam
Ahmadipour, Fatemeh
Meng, Goh Yong
Houshmand, Massoud
author_facet Dehbozorgi, Mahshid
Kamalidehghan, Behnam
Hosseini, Iman
Dehghanfard, Zahra
Sangtarash, Mohammad Hossein
Firoozi, Maryam
Ahmadipour, Fatemeh
Meng, Goh Yong
Houshmand, Massoud
author_sort Dehbozorgi, Mahshid
collection PubMed
description Polymorphisms in the cytochrome P (CYP) 450 family may cause adverse drug responses in individuals. Cytochrome P450 2C19 (CYP2C19) is a member of the CYP family, where the presence of the 681 G>A, 636 G>A and 806 C>T polymorphisms result in the CYP2C19*2, CYP2C19*3 and CYP2C19*17 alleles, respectively. In the current study, the frequency of the CYP2C19*2, CYP2C19*3 and CYP2C19*17 alleles in an Iranian population cohort of different ethnicities were examined and then compared with previously published frequencies within other populations. Allelic and genotypic frequencies of the CYP2C19 alleles (*2, *3 and *17) were detected using polymerase chain reaction (PCR)-restriction fragment length polymorphism analysis, PCR-single-strand conformation polymorphism analysis and DNA sequencing from blood samples of 1,229 unrelated healthy individuals from different ethnicities within the Iranian population. The CYP2C19 allele frequencies among the Iranian population were 21.4, 1.7, and 27.1% for the CYP2C19*2, CYP2C19*3 and CYP2C19*17 alleles, respectively. The frequency of the homozygous A/A variant of the CYP2C19*2 allele was significantly high and low in the Lur (P<0.001) and Caspian (P<0.001) ethnicities, respectively. However, the frequency of the homozygous A/A variant of the CYP2C19*3 allele was not detected in the Iranian cohort in the current study. The frequency of the heterozygous G/A variant of the CYP2C19*3 allele had the significantly highest and lowest frequency in the Fars (P<0.001) and Lur (P<0.001) groups, respectively. The allele frequency of the homozygous T/T variant of the CYP2C19*17 allele was significantly high in the Caspian (P<0.001) and low in the Kurd (P<0.05) groups. The frequency of the CYP2C19 alleles involved in drug metabolism, may improve the clinical understanding of the ethnic differences in drug responses, resulting in the advancement of the personalized medicine among the different ethnicities within the Iranian population.
format Online
Article
Text
id pubmed-5802190
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-58021902018-02-26 Prevalence of the CYP2C19*2 (681 G>A), *3 (636 G>A) and *17 (−806 C>T) alleles among an Iranian population of different ethnicities Dehbozorgi, Mahshid Kamalidehghan, Behnam Hosseini, Iman Dehghanfard, Zahra Sangtarash, Mohammad Hossein Firoozi, Maryam Ahmadipour, Fatemeh Meng, Goh Yong Houshmand, Massoud Mol Med Rep Articles Polymorphisms in the cytochrome P (CYP) 450 family may cause adverse drug responses in individuals. Cytochrome P450 2C19 (CYP2C19) is a member of the CYP family, where the presence of the 681 G>A, 636 G>A and 806 C>T polymorphisms result in the CYP2C19*2, CYP2C19*3 and CYP2C19*17 alleles, respectively. In the current study, the frequency of the CYP2C19*2, CYP2C19*3 and CYP2C19*17 alleles in an Iranian population cohort of different ethnicities were examined and then compared with previously published frequencies within other populations. Allelic and genotypic frequencies of the CYP2C19 alleles (*2, *3 and *17) were detected using polymerase chain reaction (PCR)-restriction fragment length polymorphism analysis, PCR-single-strand conformation polymorphism analysis and DNA sequencing from blood samples of 1,229 unrelated healthy individuals from different ethnicities within the Iranian population. The CYP2C19 allele frequencies among the Iranian population were 21.4, 1.7, and 27.1% for the CYP2C19*2, CYP2C19*3 and CYP2C19*17 alleles, respectively. The frequency of the homozygous A/A variant of the CYP2C19*2 allele was significantly high and low in the Lur (P<0.001) and Caspian (P<0.001) ethnicities, respectively. However, the frequency of the homozygous A/A variant of the CYP2C19*3 allele was not detected in the Iranian cohort in the current study. The frequency of the heterozygous G/A variant of the CYP2C19*3 allele had the significantly highest and lowest frequency in the Fars (P<0.001) and Lur (P<0.001) groups, respectively. The allele frequency of the homozygous T/T variant of the CYP2C19*17 allele was significantly high in the Caspian (P<0.001) and low in the Kurd (P<0.05) groups. The frequency of the CYP2C19 alleles involved in drug metabolism, may improve the clinical understanding of the ethnic differences in drug responses, resulting in the advancement of the personalized medicine among the different ethnicities within the Iranian population. D.A. Spandidos 2018-03 2018-01-05 /pmc/articles/PMC5802190/ /pubmed/29328413 http://dx.doi.org/10.3892/mmr.2018.8377 Text en Copyright: © Dehbozorgi et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle Articles
Dehbozorgi, Mahshid
Kamalidehghan, Behnam
Hosseini, Iman
Dehghanfard, Zahra
Sangtarash, Mohammad Hossein
Firoozi, Maryam
Ahmadipour, Fatemeh
Meng, Goh Yong
Houshmand, Massoud
Prevalence of the CYP2C19*2 (681 G>A), *3 (636 G>A) and *17 (−806 C>T) alleles among an Iranian population of different ethnicities
title Prevalence of the CYP2C19*2 (681 G>A), *3 (636 G>A) and *17 (−806 C>T) alleles among an Iranian population of different ethnicities
title_full Prevalence of the CYP2C19*2 (681 G>A), *3 (636 G>A) and *17 (−806 C>T) alleles among an Iranian population of different ethnicities
title_fullStr Prevalence of the CYP2C19*2 (681 G>A), *3 (636 G>A) and *17 (−806 C>T) alleles among an Iranian population of different ethnicities
title_full_unstemmed Prevalence of the CYP2C19*2 (681 G>A), *3 (636 G>A) and *17 (−806 C>T) alleles among an Iranian population of different ethnicities
title_short Prevalence of the CYP2C19*2 (681 G>A), *3 (636 G>A) and *17 (−806 C>T) alleles among an Iranian population of different ethnicities
title_sort prevalence of the cyp2c19*2 (681 g>a), *3 (636 g>a) and *17 (−806 c>t) alleles among an iranian population of different ethnicities
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5802190/
https://www.ncbi.nlm.nih.gov/pubmed/29328413
http://dx.doi.org/10.3892/mmr.2018.8377
work_keys_str_mv AT dehbozorgimahshid prevalenceofthecyp2c192681ga3636gaand17806ctallelesamonganiranianpopulationofdifferentethnicities
AT kamalidehghanbehnam prevalenceofthecyp2c192681ga3636gaand17806ctallelesamonganiranianpopulationofdifferentethnicities
AT hosseiniiman prevalenceofthecyp2c192681ga3636gaand17806ctallelesamonganiranianpopulationofdifferentethnicities
AT dehghanfardzahra prevalenceofthecyp2c192681ga3636gaand17806ctallelesamonganiranianpopulationofdifferentethnicities
AT sangtarashmohammadhossein prevalenceofthecyp2c192681ga3636gaand17806ctallelesamonganiranianpopulationofdifferentethnicities
AT firoozimaryam prevalenceofthecyp2c192681ga3636gaand17806ctallelesamonganiranianpopulationofdifferentethnicities
AT ahmadipourfatemeh prevalenceofthecyp2c192681ga3636gaand17806ctallelesamonganiranianpopulationofdifferentethnicities
AT menggohyong prevalenceofthecyp2c192681ga3636gaand17806ctallelesamonganiranianpopulationofdifferentethnicities
AT houshmandmassoud prevalenceofthecyp2c192681ga3636gaand17806ctallelesamonganiranianpopulationofdifferentethnicities